首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
被引:0
|
作者
:
Joaquín Casal Rubio
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
Joaquín Casal Rubio
S. Vázquez
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
S. Vázquez
F. Vázquez
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
F. Vázquez
M. Amenedo
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
M. Amenedo
J. L. Fírvida
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
J. L. Fírvida
J. R. Mel
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
J. R. Mel
G. Huidobro
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
G. Huidobro
E. Álvarez
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
E. Álvarez
M. Lázaro
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
M. Lázaro
G. Alonso
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
G. Alonso
I. Fernández
论文数:
0
引用数:
0
h-index:
0
机构:
Hospital do Meixoeiro,Department of Medical Oncology
I. Fernández
机构
:
[1]
Hospital do Meixoeiro,Department of Medical Oncology
[2]
Complejo Hospitalario Xeral-Calde,undefined
[3]
Hospital Arquitecto Marcide,undefined
[4]
Centro Oncológico de Galicia,undefined
[5]
Complejo Hospitalario,undefined
[6]
Hospital Juan Canalejo,undefined
[7]
Hospital Montecelo,undefined
来源
:
Cancer Chemotherapy and Pharmacology
|
2009年
/ 64卷
关键词
:
Chemotherapy;
Cisplatin;
Docetaxel;
Gemcitabine;
Non-small cell lung cancer;
Phase II trial;
D O I
:
暂无
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:379 / 384
页数:5
相关论文
共 50 条
[21]
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
Georgoulias, V
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Georgoulias, V
Ardavanis, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Ardavanis, A
Tsiafaki, X
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Tsiafaki, X
Agelidou, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Agelidou, A
Mixalopoulou, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Mixalopoulou, P
Anagnostopoulou, O
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Anagnostopoulou, O
Ziotopoulos, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Ziotopoulos, P
Toubis, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Toubis, M
Syrigos, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Syrigos, K
Samaras, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Samaras, N
Polyzos, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Polyzos, A
Christou, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Christou, A
Kakolyris, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Kakolyris, S
Kouroussis, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Kouroussis, C
Androulakis, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Androulakis, N
Samonis, G
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Samonis, G
Chatzidaki, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Crete, Greece
Chatzidaki, D
JOURNAL OF CLINICAL ONCOLOGY,
2005,
23
(13)
: 2937
-
2945
[22]
Gemcitabine-docetaxel versus cisplatin.-vinorelbine in advanced or metastatic non-small-cell lung cancer:: a phase III study addressing the case for cisplatin
Pujol, JL
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Pujol, JL
Breton, JL
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Breton, JL
Gervais, R
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Gervais, R
Rebattu, P
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Rebattu, P
Depierre, A
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Depierre, A
Morére, JF
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Morére, JF
Milleron, B
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Milleron, B
Debieuvre, D
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Debieuvre, D
Castéra, D
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Castéra, D
Souquet, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Souquet, PJ
Moro-Sibilot, D
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Moro-Sibilot, D
Lemarié, E
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Lemarié, E
Kessler, R
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Kessler, R
Janicot, H
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Janicot, H
Braun, D
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Braun, D
Spaeth, D
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Spaeth, D
Quantin, X
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Quantin, X
Clary, C
论文数:
0
引用数:
0
h-index:
0
机构:
Montpellier Univ Hosp, Montpellier, France
Clary, C
ANNALS OF ONCOLOGY,
2005,
16
(04)
: 602
-
610
[23]
Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
Antón, A
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Antón, A
Díaz-Fernández, N
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Díaz-Fernández, N
Larriba, JG
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Larriba, JG
Vadell, C
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Vadell, C
Masutti, B
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Masutti, B
Montalar, J
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Montalar, J
Barneto, I
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Barneto, I
Artal, A
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Artal, A
Rosell, R
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Miguel Servet Zaragoza, Med Oncol Serv, Zaragoza 50009, Spain
Rosell, R
LUNG CANCER,
1998,
22
(02)
: 139
-
148
[24]
Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
Laack, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Laack, E
Mende, T
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Mende, T
Dürk, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Dürk, H
Kneba, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Kneba, M
Dickgreber, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Dickgreber, N
Welte, T
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Welte, T
Müller, T
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Müller, T
Scholtze, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Scholtze, J
Graeven, U
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Graeven, U
Jasiewicz, Y
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Jasiewicz, Y
Edler, L
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Edler, L
Hossfeld, DK
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hamburg, Hosp Eppendorf, Dept Haematol & Oncol, D-20246 Hamburg, Germany
Hossfeld, DK
EUROPEAN JOURNAL OF CANCER,
2002,
38
(05)
: 654
-
660
[25]
A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
Vadell-Nadal, C
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp del Mar, Dept Clin Oncol, Barcelona 08003, Spain
Vadell-Nadal, C
Nogué-Aliguer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp del Mar, Dept Clin Oncol, Barcelona 08003, Spain
Nogué-Aliguer, M
Fabregat-Mayol, X
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp del Mar, Dept Clin Oncol, Barcelona 08003, Spain
Fabregat-Mayol, X
Saigí-Grau, E
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp del Mar, Dept Clin Oncol, Barcelona 08003, Spain
Saigí-Grau, E
Gallén-Castillo, M
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp del Mar, Dept Clin Oncol, Barcelona 08003, Spain
Gallén-Castillo, M
LUNG CANCER,
2000,
28
(02)
: 109
-
115
[26]
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
Pallis, AG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Pallis, AG
Agelidou, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Agelidou, A
Papakotoulas, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Papakotoulas, P
Tsaroucha, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Tsaroucha, A
Agelidou, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Agelidou, M
Agelaki, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Agelaki, S
Androulakis, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Androulakis, N
Vamvakas, L
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Vamvakas, L
Gerogianni, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Gerogianni, A
Kotsakis, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Kotsakis, A
Kentepozidis, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Kentepozidis, N
Georgoulias, V
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
Georgoulias, V
LUNG CANCER,
2006,
52
(02)
: 165
-
171
[27]
A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
Abratt, RP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
Abratt, RP
Bezwoda, WR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
Bezwoda, WR
Goedhals, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
Goedhals, L
Hacking, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
Hacking, DJ
EUROPEAN JOURNAL OF CANCER,
1995,
31A
: 1086
-
1086
[28]
Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
Johan Vansteenkiste
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Johan Vansteenkiste
Jean-Luc Canon
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Jean-Luc Canon
Henrik Riska
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Henrik Riska
Robert Pirker
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Robert Pirker
Patrick Peterson
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Patrick Peterson
William John
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
William John
Pekka Mali
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Pekka Mali
Michael Lahn
论文数:
0
引用数:
0
h-index:
0
机构:
Universitair Ziekenhuis Gasthuisberg,Oncology Therapeutic Area, Lilly Research Laboratories
Michael Lahn
Investigational New Drugs,
2005,
23
: 263
-
269
[29]
Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
Vansteenkiste, J
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Vansteenkiste, J
Canon, JL
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Canon, JL
Riska, H
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Riska, H
Pirker, R
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Pirker, R
Peterson, P
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Peterson, P
John, W
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
John, W
Mali, P
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Mali, P
Lahn, M
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Oncol Therapeut Area, Indianapolis, IN 46285 USA
Lahn, M
INVESTIGATIONAL NEW DRUGS,
2005,
23
(03)
: 263
-
269
[30]
Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma
Abratt, RP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN, DEPT RADIAT ONCOL, ZA-7925 CAPE TOWN, SOUTH AFRICA
Abratt, RP
Hacking, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN, DEPT RADIAT ONCOL, ZA-7925 CAPE TOWN, SOUTH AFRICA
Hacking, DJ
Goedhals, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN, DEPT RADIAT ONCOL, ZA-7925 CAPE TOWN, SOUTH AFRICA
Goedhals, L
Bezwoda, WR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CAPE TOWN, DEPT RADIAT ONCOL, ZA-7925 CAPE TOWN, SOUTH AFRICA
Bezwoda, WR
SEMINARS IN ONCOLOGY,
1997,
24
(03)
: 818
-
823
←
1
2
3
4
5
→